Log In
BCIQ
Print this Print this
 

SNX-001 New Formulation

  Manage Alerts
Collapse Summary General Information
Company SeneXta Therapeutics S.A.
DescriptionOral long-lasting acetylcholinesterase (AChE) inhibitor
Molecular Target Acetylcholinesterase (AChE)
Mechanism of ActionAcetylcholinesterase (AChE) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today